Insmed Ownership | Who Owns Insmed?
Insmed Ownership Summary
Insmed is owned by 110.75% institutional investors, 0.61% insiders. Jpmorgan chase is the largest institutional shareholder, holding 12.18% of INSM shares. JPMorgan Large Cap Growth I is the top mutual fund, with 3.36% of its assets in Insmed shares.
INSM Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Insmed | 110.75% | 0.61% | -11.37% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Jpmorgan chase | 23.05M | 12.18% | $3.32B |
| Darwin global management | 20.46M | 10.81% | $2.90B |
| Vanguard group | 19.94M | 10.53% | $2.87B |
| Blackrock | 14.26M | 9.61% | $955.72M |
| Blackrock funding, inc. /de | 12.36M | 6.53% | $1.78B |
| Fmr | 9.18M | 4.85% | $1.32B |
| Capital investors | 7.55M | 3.99% | $1.09B |
| Price t rowe associates inc /md/ | 6.93M | 3.66% | $998.20M |
| Baker bros. advisors lp | 6.70M | 3.54% | $965.37M |
| Artisan partners limited partnership | 4.94M | 2.61% | $711.08M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Darwin global management | 20.46M | 80.54% | $2.90B |
| Sio capital management | 1.36M | 24.71% | $91.30M |
| Artia global partners lp | 732.21K | 16.69% | $105.45M |
| Integral health asset management | 1.60M | 15.59% | $230.42M |
| Palo alto investors lp | 491.81K | 13.11% | $70.82M |
| Patient square capital lp | 326.40K | 12.57% | $47.00M |
| Eagle health investments lp | 271.60K | 10.27% | $39.11M |
| Duquesne family office | 2.42M | 8.59% | $349.00M |
| Nwi management lp | 1.02M | 8.12% | $147.03M |
| Baker bros. advisors lp | 6.70M | 6.98% | $965.37M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Jpmorgan chase | 23.05M | 0.20% | 7.41M |
| Fmr | 9.18M | 0.07% | 4.09M |
| Blackrock | 14.26M | 0.02% | 2.46M |
| Vanguard group | 19.94M | 0.04% | 2.29M |
| Norges bank | 1.83M | 0.02% | 1.83M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Price t rowe associates inc /md/ | 6.93M | 0.11% | -4.30M |
| Deep track capital, lp | - | - | -1.75M |
| Adage capital partners gp | 1.25M | 0.29% | -1.61M |
| Eversept partners, lp | - | - | -1.09M |
| Vestal point capital, lp | - | - | -1.07M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 1.83M | 0.02% | 1.83M | $126.61M |
| Kynam capital management, lp | 1.00M | 5.17% | 1.00M | $67.00M |
| Bank of nova scotia | 506.25K | 0.13% | 506.25K | $72.90M |
| Ing groep nv | 373.50K | 0.29% | 373.50K | $53.79M |
| Samlyn capital | 292.64K | 0.58% | 292.64K | $42.14M |
Sold Out
| Holder | Change |
|---|---|
| Nemes rush group | -3.00 |
| Raleigh capital management | -4.00 |
| Wealthtrak capital management | -5.00 |
| Riverview trust | -6.00 |
| Cva family office | -6.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 601 | 10.07% | 209,660,324 | 4.31% | 110 | 0.98% | 317 | 12.01% | 193 | -1.03% |
| Jun 30, 2025 | 548 | 17.85% | 210,291,427 | 6.07% | 111 | 0.92% | 279 | 16.25% | 198 | 28.57% |
| Mar 31, 2025 | 18 | -96.26% | 8,467,233 | -95.61% | 4 | 0.04% | 10 | -95.95% | 4 | -97.39% |
| Dec 31, 2024 | 441 | -2.86% | 179,579,885 | -3.86% | 103 | 0.89% | 220 | -15.38% | 144 | 25.22% |
| Sep 30, 2024 | 451 | 3.68% | 186,766,280 | 6.62% | 107 | 0.77% | 258 | -4.80% | 115 | 18.56% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| JPMorgan Large Cap Growth I | 7.10M | 3.36% | 1.57M |
| Vanguard US Total Market Shares ETF | 5.46M | 3.00% | 368.94K |
| Vanguard Total Stock Mkt Idx Inv | 5.75M | 2.72% | -128.70K |
| Capital Group Growth Fnd of Amer Comp | 4.74M | 2.49% | 196.69K |
| American Funds Growth Fund of Amer A | 4.74M | 2.49% | 196.69K |
| iShares Russell 2000 ETF | 4.32M | 2.41% | - |
| Vanguard Small Cap Index | 4.42M | 2.09% | -28.14K |
| US Small-Cap Growth II Equity Comp | 3.62M | 1.90% | -996.88K |
| BioPharma Credit Ord | 3.17M | 1.67% | 838.84K |
| Vanguard Small Cap Growth Index Inv | 2.49M | 1.18% | -5.21K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 05, 2025 | SHAROKY MELVIN MD | - | Sell | $4.10M |
| Dec 04, 2025 | Lewis William | Chair and CEO | Sell | $215.72K |
| Dec 04, 2025 | Lewis William | Chair and CEO | Sell | $924.06K |
| Dec 04, 2025 | Lewis William | Chair and CEO | Sell | $456.98K |
| Dec 04, 2025 | Lewis William | Chair and CEO | Sell | $603.16K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | 30 |
| 2025 Q3 | - | 43 |
| 2025 Q2 | 2 | 70 |
| 2025 Q1 | - | 87 |
| 2024 Q4 | - | 10 |
INSM Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools